Zantac strategic research guidebook

All the
legal work, none
of the hassle

Own it for $199

Read a free sample Read a free sample below

Research findings

From 65+ studies, investigations, and reports from Zantac's effects

Intake criteria

For prospective Zantac plaintiffs plus pre-existing conditions that complicate eligibility

Causation data

Demonstrating strength of association between Zantac and various cancers

Liability arguments

Against parties involved in Zantac’s development

Strategy recommendations

To maximize damage assessments for Zantac plaintiffs

Expert Opinions

From specialists in FDA drug safety, medical toxicology, pharmacology, and more

Read a free sample of the guidebook

  • This field is for validation purposes and should be left unchanged.

The guidebook was compiled by a team of physicians, researchers, and industry experts.

Ricky Siddiqui

Ricky Siddiqui, M.S., M.P.H

Medical Research

Meriem Seghier

Meriem Seghier M.D.

Medical Research

Mariam Ghantous M.D.

Medical Research

Meredith Kalberer B.S.

Medical Research

Step 1 of 3


Next: Payment

Secured by